CPC Launches Biopharma's Largest Aseptic Connector

22 April 2023 | Saturday | News

CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical processing, today announced the launch of its AseptiQuik® W Series, the industry's largest genderless aseptic connectors. The new 1-1/2-inch flow path solution easily transfers hundreds of liters per minute, significantly reducing fluid transfer times across bioprocesses.

"Biopharma manufacturers continue to press the boundaries of single-use technologies (SUTs) in nearly all of their production processes, including the use of containers larger than 2,000 liters and higher efficiency filtration devices," said Michael Francis, Product Manager at CPC. "The AseptiQuik W's new, large-format connection technology handles flow rates that meet these challenging application requirements."

CPC also pioneered the 1/8-inch MicroCNX® Series Connectors, the industry's smallest connectors and the only alternative to tube welding for the creation of closed sterile connections at small volumes.

"These latest solutions further expand CPC's aseptic connector portfolio, solidifying its position as the broadest in our industry. We are proud of our continued innovation to meet the evolving needs of cell therapy, gene therapy and biopharma manufacturers across the globe," Francis continued.

CPC will showcase the new AseptiQuik W connectors along with the company's full portfolio of biopharmaceutical process solutions at the upcoming 2023 INTERPHEX Show, which will be held from April 25-27, 2023, at the Javits Center in New York City.

AseptiQuik W connector hose barb termination sizes include 1-inch, 1-1/4-inch, and 1-1/2-inch with a 1-1/2-inch sanitary flange option. Applications include fluid transfer and filtration processes for up to 5,000 liters, comprising media, buffer and cell culture processes.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close